Survival Patterns in United States (US) Medicare Enrollees with Non-CML Myeloproliferative Neoplasms (MPN)

• Published in: PloS one Vol. 9; no. 3; p. e90299
• Main Authors: Price, Gregory L., Davis, Keith L., Karve, Sudeep, Pohl, Gerhardt, Walgren, Richard A.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 11.03.2014; Public Library of Science (PLoS)
• Subjects: Adult; Aged; Aged, 80 and over; Blood; Bone marrow; Cancer; Data bases; Diagnosis; Epidemiology; Female; Government programs; Health care; Human subjects; Humans; Leukemia; Life expectancy; Male; Medical diagnosis; Medical prognosis; Medicare; Medicine; Middle Aged; Mortality; Myelofibrosis; Myeloproliferative Disorders - epidemiology; Myeloproliferative Disorders - mortality; Neoplasms; Older people; Patients; Polycythemia; Polycythemia vera; Population; Proportional Hazards Models; Public Health Surveillance; Retrospective Studies; SEER Program; Studies; Survival; Trends; Tumors; United States - epidemiology; United States

Non-CML myeloproliferative neoplasms (MPN) include essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Reported median overall survival (OS) ranges from a few to several years for MF, a decade or more for ET and PV. The study objective was to compare US survival rates of...